No Data
No Data
Stella Pharma: Financial results briefing materials for the 2nd quarter of the fiscal year ending March 31, 2025
TAE Life Sciences and Stella Pharma Announce Strategic Agreement for Development and Commercialization of BPA for BNCT Cancer Therapy in the USA and Europe
Stella Pharma: Confirmation letter
Stella Pharma: Half Year Report - Term 18 (2024/04/01 - 2025/03/31)
Stella Pharma: Supplemental financial results for the 2nd quarter of the fiscal year ending March 31, 2025
Stella Pharma: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending 2025/3 [Japanese GAAP] (unconsolidated)
No Data
No Data